Your browser doesn't support javascript.
Fulminant type 1 diabetes after COVID-19 vaccination.
Tang, Xiaohan; He, Binbin; Liu, Zhenqi; Zhou, Zhiguang; Li, Xia.
  • Tang X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Furong District, Cha
  • He B; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Furong District, Cha
  • Liu Z; Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Furong District, Cha
  • Li X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Furong District, Cha
Diabetes Metab ; 48(2): 101324, 2022 03.
Article in English | MEDLINE | ID: covidwho-1757264

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article